Oric Pharmaceuticals

Oric Pharmaceuticals

ORIC· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +1.4% in FY2025

Jacob M. Chacko, M.D. is the CEO of Oric Pharmaceuticals and was paid $5.6M in FY2025 (Dec), up 5%.

Pay$100 in the stock at the end of FY21 → $56
CEO pay is from each Oric Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Jacob M. Chacko, M.D.FY2025
  2. 2Pratik S. Multani, M.D.FY2025
  3. 3Dominic PiscitelliFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Oric Pharmaceuticals paid its 3 named executives $10.1M in total in FY2025 (Dec). CEO Jacob M. Chacko, M.D. was paid $5.6M of that.

Name
Jacob M. Chacko, M.D.President and Chief Executive Officer
Pratik S. Multani, M.D.Chief Medical OfficerNot disclosed
Dominic PiscitelliChief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Oric Pharmaceuticals. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 28, 2026FY2025
Annual report10-KFeb 23, 2026FY2025
Proxy statementDEF 14AApr 23, 2025FY2024
Annual report10-KFeb 18, 2025FY2024
Proxy statementDEF 14AApr 24, 2024FY2023
Annual report10-KMar 11, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data